In Surprise Move, Panel Stops Adding Cases To Opioid MDL
The Judicial Panel on Multidistrict Litigation unexpectedly ruled late Friday that a huge and historic MDL for opioid crisis lawsuits against pharmaceutical companies has accomplished key objectives and doesn't offer enough...To view the full article, register now.
Already a subscriber? Click here to view full article